All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Northwestern study identifies schizophrenia biomarker and potential drug candidate for cognitive symptoms

By

gmays

2mo ago· 4 min readenNews

Summary

A Northwestern University study in humans and mice has identified a novel biomarker for schizophrenia that could also serve as a drug candidate to treat cognitive symptoms like disorganized thinking and executive dysfunction. Current schizophrenia medications effectively treat hallucinations and delusions but do little for cognitive symptoms. The research points to a new pathway for addressing these neglected aspects of the disorder, which affects about 0.5% of the global population.

Key quotes

· 3 pulled
Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms like disorganized thinking or executive dysfunction.
A new Northwestern study in humans and mice has discovered a novel biomarker of schizophrenia that could also serve as a new drug candidate to treat the disorder's cognitive symptoms.
Schizophrenia affects .5% of the world's population, including about two million people in the U.S.
Snippet from the RSS feed
A new Northwestern University study in humans and mice has discovered a novel biomarker of schizophrenia that could also serve as a new drug candidate to treat the cognitive symptoms of the disorder. Schizophrenia affects .5% of the world’s population, in

You might also wanna read